Immunome (NasdaqCM:IMNM) FY Conference Transcript

Immunome (NasdaqCM:IMNM) FY Conference September 09, 2025 01:00 PM ET Speaker0Everyone, welcome to our annual global investment conference. My name is Li Chen. I'm an equity researcher associate with Douglas Hao. So next presenting company we have is ImmuNO. With us today is mister Clay Siegel, president and CEO of immuno, a clinical stage biotech company developing novel therapies including gamma secretase inhibitor and ADCs for cancer treatment.Please go ahead.Speaker1Thank you very much for the opportuni ...